Sarvee Integra Private Limited
About Sarvee Integra Private Limited
Data last updated:
Sarvee Integra Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 26 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2016PTC113890. Its GSTIN is 33AAXCS9586M1Z2 (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kadalraja Raghavan and Thiruselvi Devasena.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at O.No:31 N.No:61 Bheemasena Garden Street Mylapore, Chennai, Tamil Nadu, India – 600004.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.26 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹48,099 (net margin -0.4%) and EBITDA of ₹1.02 Lakh (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 258% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sarvee Integra Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressO.No:31 N.No:61 Bheemasena Garden Street Mylapore, Chennai, Tamil Nadu, India – 600004
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Sarvee Integra Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sarvee Integra is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sarvee Integra Private Limited, buy the company report.
Financials of Sarvee Integra Private Limited
FY 2025 filings availableSarvee Integra Private Limited reported revenue of ₹1.26 Cr (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 258% over five years, including 29% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.02 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹48,099 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sarvee Integra Private Limited, buy the company report.
Board of directors of Sarvee Integra Private Limited
Sarvee Integra has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kadalraja Raghavan Also directs: Kenmax Medical Services Private Limited | Director | 26 Dec 2016 | 9 Years 9 Months | Current |
| Thiruselvi Devasena | Director | 26 Dec 2016 | 9 Years 9 Months | Current |
| Raghavan Kirankumar | Additional Director | 16 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
Sarvee Integra Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sakya Sales and Solutions Private Limited | ₹1.26 Cr (FY 2024) | 1293.0% | Indore, Madhya Pradesh, India | |||
| Narix Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2025) | 61.0% | Mumbai, Maharashtra, India | |||
| Douglas Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2025) | -18.0% | Hyderabad, Telangana, India | |||
| Sarvee Integra Private Limitedthis company | ₹1.26 Cr (FY 2025) | -₹48,099 | -0.4% | 29.0% | Chennai, Tamil Nadu, India | |
| Macron Biotech Private Limited | ₹1.26 Cr (FY 2017) | 16.0% | Varanasi, Uttar Pradesh, India | |||
| RMR Formulation Private Limited | ₹1.26 Cr (FY 2025) | 44.0% | Kholvad, Gujarat, India | |||
| Avic Remedies Private Limited | ₹1.26 Cr (FY 2025) | 5.0% | Neemuch, Madhya Pradesh, India |
To see the full peer comparison of Sarvee Integra Private Limited, buy the company report.
Auditor
Sarvee Integra Private Limited is audited by Peri Thiagraj & Co for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Peri Thiagraj & Co | FY 2017 | 002636S |
Shareholding
The shareholding of Sarvee Integra Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sarvee Integra Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sarvee Integra Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sarvee Integra Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sarvee Integra has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAXCS9586M1Z2 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sarvee Integra Private Limited, buy the company report.
Recent activity
Sarvee Integra Private Limited has 5 board changes on record since 2016: 4 appointments and 1 cessation. The latest: Pavithraa ceased to be Additional Director on 19 Mar 2025.
Frequently asked questions
Sarvee Integra is an active private limited company based in Chennai, Tamil Nadu, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 26 December 2016 (10+ years old) and is registered under CIN U74999TN2016PTC113890.
Sarvee Integra has 3 current directors:
- Kadalraja Raghavan - Director
- Thiruselvi Devasena - Director
- Raghavan Kirankumar - Additional Director
The latest financial statements of Sarvee Integra on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Sarvee Integra is 33AAXCS9586M1Z2, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Sarvee Integra is U74999TN2016PTC113890. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sarvee Integra was incorporated on 26 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Sarvee Integra by revenue are Sakya Sales and Solutions Private Limited, Narix Pharmaceuticals Private Limited, Douglas Pharmaceuticals Private Limited, Macron Biotech Private Limited, RMR Formulation Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Pavithraa ceased to be Additional Director on 19 Mar 2025. Pavithraa was appointed as Additional Director on 16 Apr 2022. Raghavan Kirankumar was appointed as Additional Director on 16 Apr 2022. Sarvee Integra has 5 board changes on record in total.
The registered office of Sarvee Integra is at O.No:31 N.No:61 Bheemasena Garden Street Mylapore, Chennai, Tamil Nadu, India – 600004.
Sarvee Integra operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Sarvee Integra is compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.